Yang Yin Fu Zheng Therapy in HBV Associated Hepatocellular Carcinoma
Status:
Completed
Trial end date:
2018-12-01
Target enrollment:
Participant gender:
Summary
Clinical research of Yang Yin Fu Zheng therapy in HBV associated hepatocellular carcinoma
basing on immune microenviroment.The purpose of this study is to observe the efficacy of
routine medical care combined with Yang Yin Fu Zheng therapy for patients belong to HBV-HCC.